Theratechnologies Secures US Patent for its Novel Peptide TH1173

Jan 29, 2013
PDF Version
Supporting Materials:

Theratechnologies Inc. (TSX: TH) (NASDAQ: THER) today reported that the US Patent and Trademark Office (USPTO) has granted a patent (US Patent No. 8,361,964) for its second generation growth-hormone releasing factor (GRF) peptide, TH1173, providing for patent protection beyond 2030.